期刊文献+

氨甲环酸制剂开发的研究进展 被引量:10

Research Advance in Preparation Development of Tranexamic Acid
下载PDF
导出
摘要 目的为氨甲环酸的制剂开发、临床应用和新药研发提供依据。方法检索PubMed,Medline,EMBASE/EM,IPA及CNKI等数据库中2013年5月前有关氨甲环酸制剂开发及临床应用的相关文献及专利,并进行分析。结果研制开发的氨甲环酸制剂有普通及缓释片剂、胶囊剂、糖浆剂、注射剂、吸收性止血海绵、含漱液、复方制剂及乳剂、溶液剂、脂质体等外用制剂,氨甲环酸对治疗纤维蛋白溶解亢进所致的各种出血、月经过多、黄褐斑等具有良好的疗效和耐受性。结论应促进临床安全、合理用药,进一步开发新型的氨甲环酸药物制剂。 Objective To provide a reference for the clinical applications and preparation development of tranexamic acid and the re- search and development of new drugs. Methods The related literature and patents on the preparation development and clinical applica- tion of tranexamic acid from the databases of PubMed, Medline, EMBASE/EM, IPA and CNKI before May 2013 were retrieved and ana- lyzed. Results The researched and developed preparations of tranexamic acid include ordinary and sustained- release tablets, capsules, syrups, injections, absorbable hemostatic sponge, gargles, compound preparations and topical preparations such as emulsion, solution and li- posome. Tranexamic acid has good efficacy and tolerability for the treatment of various bleeding, menorrhagia and melasma caused by fibrinolysis hyperfunction. Conclusion The basis and reference for promoting the rational drug use and further development of new tranexamic acid preparations are provided.
出处 《中国药业》 CAS 2014年第7期1-4,共4页 China Pharmaceuticals
关键词 氨甲环酸 制剂开发 临床应用 tranexamic acid development of preparations clinical applications
  • 相关文献

参考文献39

  • 1张象麟.氨甲环酸[M].成都:四川科学技术出版社,2008:828-829. 被引量:2
  • 2The European Agency for the Evaluation of Medicinal Products. Committee for Propritary Medicinal Products(CPMP)opinion following an article 10 referral: Cyklo - f(tranexamic acid) [EB/OL]. (2000 - 07 - 27) [2013 - 05 - ! 3 ] . http: //www. ema. europa, eu/docs/en GB/documentJibrary/ Referrals_document / C yklo_f_29 / W C500011080, pdf. 被引量:1
  • 3Ferring Pharmaceuticals, Inc. Lysteda (tranexamic acid) label information [EB/OL] . (2009 - 11 - 13) [2013 -05 - 13] . http://www, accessdata. fda. gov/scripts/cder/drugsatfda/index, cfm? fuseaction = Search. Drug Details. 被引量:1
  • 4Pilbrant A, Scbannong M, Vessman J. Pbarmacokinetics and bioavailability of tranexamic acid [ J ]. Eur J Clin Pharmacol, 1981,20 ( 1 ) : 65 - 72. 被引量:1
  • 5Cho/-IH, Choi M, Cho S, et al. Role of oral tranexamic acid in naelasma pa- tients treated with IPL and low fluence QS Nd: YAG laser [J]. J Derma- tolog Treat, 2013,24 (4) : 292 - 296. 被引量:1
  • 6Na JI, Choi SY, Yang SH, et al. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation [J ]. J Eur Acad Dermatol Venere- ol,2013,27(8):1 035 -1 039. 被引量:1
  • 7吴溯帆,石杭燕,陈永,师丽丽,严晟,陈达,郭金才,韩菲.口服氨甲环酸治疗黄褐斑的临床观察[J].中国美容整形外科杂志,2008,19(2):106-110. 被引量:65
  • 8陆海山,郭剑,陈智勇,赵启明,甘精兵,周蓉蓉,吴近芳.氨甲环酸联合还原型谷胱甘肽治疗黄褐斑的临床观察[J].浙江中医药大学学报,2011,35(6):873-874. 被引量:12
  • 9陈丽梅,孙乐琪,周媛媛,朱巧燕,周利娟,叶丽丽.微晶磨面联合氨甲环酸治疗黄褐斑的疗效观察[J].中国美容医学,2010,19(11):1670-1671. 被引量:9
  • 10邸星星,韦文朗,杨敬娟,韦炫羽,张晶晶.E光联合口服氨甲环酸治疗黄褐斑疗效观察[J].中国美容医学,2011,20(12):1940-1941. 被引量:4

二级参考文献70

共引文献77

同被引文献92

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部